↓ Skip to main content

Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India

Overview of attention for article published in Malaria Journal, July 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog

Readers on

mendeley
101 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India
Published in
Malaria Journal, July 2014
DOI 10.1186/1475-2875-13-284
Pubmed ID
Authors

Neelima Mishra, Kamlesh Kaitholia, Bina Srivastava, Naman K Shah, Jai Prakash Narayan, Vas Dev, Sobhan Phookan, Anupkumar R Anvikar, Roma Rana, Ram Suresh Bharti, Gagan Singh Sonal, Akshay Chand Dhariwal, Neena Valecha

Abstract

Anti-malarial drug resistance in Plasmodium falciparum in India has historically travelled from northeast India along the Myanmar border. The treatment policy for P. falciparum in the region was, therefore, changed from chloroquine to artesunate (AS) plus sulphadoxine-pyrimethamine (SP) in selected areas in 2005 and in 2008 it became the first-line treatment. Recognizing that resistance to the partner drug can limit the useful life of this combination therapy, routine in vivo and molecular monitoring of anti-malarial drug efficacy through sentinel sites was initiated in 2009.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Burkina Faso 1 <1%
Ghana 1 <1%
Unknown 97 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 22%
Student > Master 17 17%
Student > Ph. D. Student 16 16%
Student > Bachelor 7 7%
Student > Doctoral Student 6 6%
Other 17 17%
Unknown 16 16%
Readers by discipline Count As %
Medicine and Dentistry 28 28%
Biochemistry, Genetics and Molecular Biology 18 18%
Agricultural and Biological Sciences 13 13%
Nursing and Health Professions 3 3%
Immunology and Microbiology 3 3%
Other 17 17%
Unknown 19 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2019.
All research outputs
#2,455,982
of 22,768,097 outputs
Outputs from Malaria Journal
#554
of 5,554 outputs
Outputs of similar age
#26,170
of 228,560 outputs
Outputs of similar age from Malaria Journal
#13
of 98 outputs
Altmetric has tracked 22,768,097 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,554 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,560 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.